Non-small-cell lung cancer (NSCLC) represents a common health issue in the elderly
population. Nevertheless, the paucity of large, well-conducted prospective trials makes it …

Background The optimal treatment of stage I non–small-cell lung carcinoma is subject to
debate. The aim of this study was to compare overall survival and oncologic outcomes of …

Purpose Non–small-cell lung cancer (NSCLC) is predominantly a disease of the elderly.
Retrospective analyses of the National Cancer Institute of Canada Clinical Trials Group JBR …

BACKGROUND: The treatment, prognosis, and outcomes of young lung cancer patients
have not been fully explored. In addition, there is a pressing need to characterize this …

Background: Non-small cell lung cancer (NSCLC) in young adults is a rare but devastating
illness with significant socioeconomic implications, and studies of this patient subgroup are …

Introduction Non-small cell lung cancer (NSCLC) patients frequently have major
comorbidities but there is scarce data regarding the impact of these conditions on …

Background Reports on the temporal evolution in lung resection are limited. To elucidate
temporal changes in the demographics of lung resections, we analyzed nationally …

Objectives: The aim of this study was to describe the demographic and clinico-pathological
characteristics of lung cancer in patients younger than 40 years. Materials and Methods …

Background Risk factors that contribute to younger patients with lung cancer are still
relatively unknown. The aim of this study was to compare the clinical characteristics …

Background Brain metastases confer significant morbidity and a poorer survival in non-small
cell lung cancer (NSCLC). Vascular endothelial growth factor-targeted antiangiogenic …